TY - JOUR
T1 - NanoCAGE reveals 5' UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs
AU - Gandin, Valentina
AU - Masvidal, Laia
AU - Hulea, Laura
AU - Gravel, Simon Pierre
AU - Cargnello, Marie
AU - McLaughlan, Shannon
AU - Cai, Yutian
AU - Balanathan, Preetika
AU - Morita, Masahiro
AU - Rajakumar, Arjuna
AU - Furic, Luc
AU - Pollak, Michael
AU - Porco, John A.
AU - St-Pierre, Julie
AU - Pelletier, Jerry
AU - Larsson, Ola
AU - Topisirovic, Ivan
N1 - Funding Information:
This work is dedicated to the memory of Colin Lister. We thank Alvin Kuate Defo for assistance, Drs. J. Timmons, L. Lindqvist, O. Meyuhas, C. Plessy, and R. Dikstein for editing and critical input, suggestions on nanoCAGE sequencing, and TISU element search, respectively. We acknowledge support from Science for Life Laboratory, the Knut and Alice Wallenberg Foundation, the National Genomics Infrastructure funded by the Swedish Research Council, and Uppsala Multidisciplinary Center for Advanced Computational Science for assistance with massively parallel sequencing and access to the UPPMAX computational infrastructure. The LDI flowcytometry facility is supported in part by MSSS and CFI (223964). This research was supported by the Swedish Research Council, the Swedish Childhood Cancer Foundation, the Swedish Cancer Society, the Cancer Society in Stockholm, the Wallenberg Academy Fellows Program, and STRATCAN grants (O.L.), grants from the Canadian Institutes of Health Research (MOP-115195 to I.T., MOP-115126 to J.P., and MOP-106603 to J. St-P.), the Terry Fox Research Institute (TFF 116128) to I.T., J. St-P., and M.P., and National Institutes of Health R01 grant (GM073855, J.A.P. Jr.). Research in the BUCMD was supported by National Institutes of Health grant GM067041, Swedish Foundation for International Cooperation in Research and Higher Education (STINT) (O.L., I.T., and L.F.). I.T. is a CIHR New Investigator and recipient of an FRQS establishment award. J. St-P. is a FRQS scholar. L.M. is supported by a postdoctoral fellowship from the Swedish Childhood Cancer Foundation. M.C. and Y.C. hold fellowships from the CIHR/ FRQS training grant in cancer research FRN53888 of the McGill Integrated Cancer Research Training Program. I.T. is indebted to Prof. R. McInnes for allowing him to focus on science and for the constructive criticism and help with this project.
Publisher Copyright:
© 2016 Gandin et al.
PY - 2016/5
Y1 - 2016/5
N2 - The diversity of MTOR-regulated mRNA translation remains unresolved. Whereas ribosome-profiling suggested that MTOR almost exclusively stimulates translation of the TOP (terminal oligopyrimidine motif) and TOP-like mRNAs, polysome- profiling indicated that MTOR also modulates translation of mRNAs without the 5' TOP motif (non-TOP mRNAs). We demonstrate that in ribosome-profiling studies, detection of MTOR-dependent changes in non-TOP mRNA translation was obscured by low sensitivity and methodology biases. Transcription start site profiling using nano-cap analysis of gene expression (nanoCAGE) revealed that not only do many MTOR-sensitive mRNAs lack the 5' TOP motif but that 5' UTR features distinguish two functionally and translationally distinct subsets of MTOR-sensitive mRNAs: (1) mRNAs with short 5' UTRs enriched for mitochondrial functions, which require EIF4E but are less EIF4A1-sensitive; and (2) long 5' UTR mRNAs encoding proliferation- and survival-promoting proteins, which are both EIF4E- and EIF4A1-sensitive. Selective inhibition of translation of mRNAs harboring long 5' UTRs via EIF4A1 suppression leads to sustained expression of proteins involved in respiration but concomitant loss of those protecting mitochondrial structural integrity, resulting in apoptosis. Conversely, simultaneous suppression of translation of both long and short 5' UTR mRNAs by MTOR inhibitors results in metabolic dormancy and a predominantly cytostatic effect. Thus, 5' UTR features define different modes of MTOR-sensitive translation of functionally distinct subsets of mRNAs, which may explain the diverse impact of MTOR and EIF4A inhibitors on neoplastic cells.
AB - The diversity of MTOR-regulated mRNA translation remains unresolved. Whereas ribosome-profiling suggested that MTOR almost exclusively stimulates translation of the TOP (terminal oligopyrimidine motif) and TOP-like mRNAs, polysome- profiling indicated that MTOR also modulates translation of mRNAs without the 5' TOP motif (non-TOP mRNAs). We demonstrate that in ribosome-profiling studies, detection of MTOR-dependent changes in non-TOP mRNA translation was obscured by low sensitivity and methodology biases. Transcription start site profiling using nano-cap analysis of gene expression (nanoCAGE) revealed that not only do many MTOR-sensitive mRNAs lack the 5' TOP motif but that 5' UTR features distinguish two functionally and translationally distinct subsets of MTOR-sensitive mRNAs: (1) mRNAs with short 5' UTRs enriched for mitochondrial functions, which require EIF4E but are less EIF4A1-sensitive; and (2) long 5' UTR mRNAs encoding proliferation- and survival-promoting proteins, which are both EIF4E- and EIF4A1-sensitive. Selective inhibition of translation of mRNAs harboring long 5' UTRs via EIF4A1 suppression leads to sustained expression of proteins involved in respiration but concomitant loss of those protecting mitochondrial structural integrity, resulting in apoptosis. Conversely, simultaneous suppression of translation of both long and short 5' UTR mRNAs by MTOR inhibitors results in metabolic dormancy and a predominantly cytostatic effect. Thus, 5' UTR features define different modes of MTOR-sensitive translation of functionally distinct subsets of mRNAs, which may explain the diverse impact of MTOR and EIF4A inhibitors on neoplastic cells.
UR - http://www.scopus.com/inward/record.url?scp=84964949423&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84964949423&partnerID=8YFLogxK
U2 - 10.1101/gr.197566.115
DO - 10.1101/gr.197566.115
M3 - Article
C2 - 26984228
AN - SCOPUS:84964949423
SN - 1088-9051
VL - 26
SP - 636
EP - 648
JO - Genome Research
JF - Genome Research
IS - 5
ER -